Rephonic
Artwork for The Lancet Gastroenterology & Hepatology in conversation with

The Lancet Gastroenterology & Hepatology in conversation with

The Lancet Group
Inflammatory Bowel Disease
Crohn's Disease
Colorectal Cancer
Quality Of Life
Hepatitis B
Irritable Bowel Syndrome
Low FODMAP Diet
Low Carbohydrate Diet
Pharmacological Treatments
Car-Ibs Trial
Colonoscopy
Intestinal Ultrasound
ASCOLT Trial
Acute Kidney Injury
Decompensated Cirrhosis
Liver Stiffness Measurement
Peth Biomarker
Steatotic Liver Disease
Liverscreen Study
Sub-Saharan Africa

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s d... more

PublishesMonthlyEpisodes87Founded6 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for The Lancet Gastroenterology & Hepatology in conversation with

Latest Episodes

Could repeated liver stiffness measurement offer a practical approach to population-based liver fibrosis screening? In this episode, we speak with Pere Ginès about the LiverScreen study, which analysed changes in liver stiffness over time across thre... more

In children with Crohn’s disease who achieve remission through exclusive enteral nutrition, what's the optimal dietary therapy to maintain remission without the use of medication or surgery? Frank Ruemmele (Université Paris Cité) talks through the CD... more

Steatotic liver disease labels hinge on alcohol intake, but self-report is often inaccurate. In this episode, Aleksander Krag (Odense University Hospital) discusses a large Danish study using phosphatidylethanol (PEth), a direct blood biomarker of re... more

Can bacteria-free, sterile faecal filtrate match conventional faecal microbiota transplantation for recurrent C difficile infection? Dina Kao (University of Alberta) unpacks a landmark multicentre trial that tested this hypothesis, and we discuss wha... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Pere Ginès
Professor, Liver Unit Hospital Clinic Barcelona, University of Barcelona
Liver Unit Hospital Clinic Barcelona; University of Barcelona
Episode: Pere Ginès on long-term liver stiffness measurement as a screening tool for liver fibrosis
Frank Ruemmele
Professor of Pediatrics at Université Paris Cité and Head of Pediatric Gastroenterology & Nutrition at Necker-Enfant-Millard Hospital, Paris
Université Paris Cité / Necker-Enfant-Millard Hospital
Episode: Frank Ruemmele on a trial of cyclic exclusive enteral nutrition versus partial enteral nutrition to maintain remission in paediatric Crohn's disease
Aleksander Krag
Corresponding author on the study; Professor and Department Chair at Odense University Hospital
Odense University Hospital, Center for Liver Research
Episode: Aleksander Krag on the utility of PEth for subclassifying individuals at risk of steatotic liver disease
Dina Kao
Professor of Medicine focused on therapeutic manipulation of the gut microbiome and FMT for recurrent C. diff
University of Alberta
Episode: Dina Kao on a trial of lyophilised sterile faecal filtrate versus lyophilised conventional donor stool for recurrent Clostridiodes difficile infection
Premic Bercik
Professor of Medicine and Gastroenterology at McMaster University
McMaster University
Episode: Premysl Bercik on a double-blind crossover trial of gluten and wheat in IBS
Dr. Salvatore Piano
Associate Professor of Internal Medicine and Consultant Hepatologist
University and Hospital of Padua, Italy
Episode: Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis
John Chia
Consultant medical oncologist at Curie Oncology; formerly chief of gynecology oncology service at the National Cancer Centre Singapore
Curie Oncology
Episode: John Chia on the ASCOLT trial of adjuvant aspirin for colorectal cancer
Professor Hannes Hagström
Consultant in Hepatology at the Karolinska University Hospital and professor with a research focus on liver disease epidemiology.
Karolinska Institute
Episode: Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes
Dr. Cathy Lu
Associate Professor at the University of Calgary and first author of the consensus statement.
University of Calgary
Episode: Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn’s disease small bowel strictures

Host

Hugh Thomas
Deputy Editor at The Lancet Gastroenterology & Hepatology

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Frank Ruemmele on a trial of cyclic exclusive enteral nutrition versus partial enteral nutrition to maintain remission in paediatric Crohn's disease
Q: What was the rationale behind choosing cyclic exclusive enteral nutrition as the primary intervention compared with partial enteral nutrition?
The researchers aimed to test whether intermittent complete reliance on enteral nutrition could sustain remission without drugs, given that induction with exclusive nutrition is effective but drugs are typically used for maintenance; they also sought a feasible comparator that would reflect real-world adherence without a placebo.
Aleksander Krag on the utility of PEth for subclassifying individuals at risk of steatotic liver disease
Q: Can you run us through the triage algorithm and explore how it might be deployed clinically?
The host and guest describe a three-tiered approach: start with self-report and AUDIT-C, then use PATH testing for discordant or ambiguous cases, potentially reducing PATH use by about 40% in suitable patients.
Aleksander Krag on the utility of PEth for subclassifying individuals at risk of steatotic liver disease
Q: What participants were you including in this study? How were you defining the self-reported intake and the AUDIT-C and collecting that information?
The guest explains a large prospective Danish cohort including individuals with cardiometabolic risk factors, using standardized questionnaires for self-report and AUDIT-C, alongside Peth measurements.
Aleksander Krag on the utility of PEth for subclassifying individuals at risk of steatotic liver disease
Q: To kick things off then, for our listeners who don't necessarily work with steatotic liver disease and its various subclassifications every day, how is alcohol exposure currently used to distinguish between MASLD or META-LD or ALD, and why does getting that subclassification right matter?
The doctor outlines that classification is based on self-reported alcohol consumption, with thresholds that separate MASLD, META-LD, and ALD, emphasizing that accurate subclassification guides targeted treatment and prognosis.
Dina Kao on a trial of lyophilised sterile faecal filtrate versus lyophilised conventional donor stool for recurrent Clostridiodes difficile infection
Q: What do the results imply about the role of live microbes in FMT efficacy?
Results suggest live bacteria contribute significantly to efficacy, as the filtrate showed high short-term success but was not non-inferior to donor stool, and microbiome analyses revealed donor-like shifts and recovery of beneficial taxa predominantly in the conventional FMT group, indicating live microbes may be essential for full therapeutic effect.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

This series features in-depth discussions on pivotal research and breakthroughs in gastroenterology and hepatology, focusing on their implications for healthcare and health policy. Episodes cover diverse topics, from advanced liver disease management strategies to innovations in inflammatory bowel disease treatment and antibiotic resistance. Noteworthy is a strong emphasis on both clinical practice and patient-centered approaches, aiming to bridge the gap between research findings and real-world applications in healthcare settings.

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. JAMA Clinical Reviews
2. 7 minute Hepatology
3. NEJM This Week
4. JAMA Medical News
5. American Journal of Gastroenterology Author Podcasts

How many episodes of this podcast are there?

this podcast launched 6 years ago and published 87 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Pere Ginès
2. Frank Ruemmele
3. Aleksander Krag
4. Dina Kao
5. Premic Bercik
6. Dr. Salvatore Piano
7. John Chia
8. Professor Hannes Hagström

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days